Social Media and Cancer Screening Information
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Utah
-
Salt Lake City, Utah, United States, 84112
- Andy King
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Identify as white/Caucasian or Black/African American.
Exclusion Criteria:
- Do not identify as white/Caucasian or Black/African American.
- Previously diagnosed with colorectal cancer
- Non-English speakers
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Control (no exposure)
Participants in the Control Arm will not be shown any messages.
|
There will be no message content of cancer screening and sharing intentions in this arm.
|
|
Experimental: Median Ranked
Participants in the Median Ranked Arm will be shown four Median Ranked messages.
|
Strong message content that increases screening and sharing intentions.
Messages in this intervention were median ranked in the prior study.
|
|
Experimental: Overall Preferred
Participants in the Overall Preferred arm will be shown four Overall Preferred messages.
|
Strong message content that increases screening and sharing intentions.
Messages in this intervention were highly rated messages by all participants in the prior study.
|
|
Experimental: Black American Preferred
Participants in the Black American Preferred arm will be shown four Black American Preferred messages.
|
Strong message content that increases screening and sharing intentions.
Messages in this intervention were highly rated messages by Black participants but not White participants in the prior study.
|
|
Experimental: White American Preferred
Participants in the White American Preferred arm will be shown four White American Preferred messages.
|
Strong message content that increases screening and sharing intentions.
Messages in this intervention were highly rated messages by White participants but not Black participants.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intentions to Adhere to Colorectal Cancer Screening (CRCS) Recommendations
Time Frame: 15 minutes
|
After reading cancer screening (CRCS) recommendations, this outcome will assess how likely they are to follow on the the screening recommendations. Response options: Very unlikely (1), unlikely, neither unlikely nor likely, likely, very likely (5) A higher score indicates a favorable outcome, and a lower score indicates a less favorable outcome. |
15 minutes
|
|
Intentions to Adhere Test Preference Indication
Time Frame: 15 minutes
|
To determine which colorectal cancer screening (CRCS) participants are most likely to choose. Response options: stool-based tests (e.g., FOBT or FIT); endoscopic/scoping approach (e.g., colonoscopy or sigmoidoscopy); whatever my doctor recommends to me; something other than a stool-based or scoping approach; I would not follow the recommendations. This outcome will report the count of responses. |
15 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Likelihood of Sharing Information Via Social Media
Time Frame: 15 minutes
|
This outcome measure will determine how likely participants are to share the messages about colon cancer screening on social media. Response options: Very unlikely (1), unlikely, neither unlikely nor likely, likely, very likely (5) A higher score indicates a favorable outcome, and a lower score indicates a less favorable outcome. |
15 minutes
|
|
Information Sharing Behavior
Time Frame: 15 minutes
|
This outcome will report the count of participants will seek more information after the study. The participants will be asked a question on if they would like more information (Yes/No) and survey vendor will track participants who click a link to an external resource like the American Cancer Society to learn more. |
15 minutes
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Andy King, PhD, Huntsman Cancer Institute/ University of Utah
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HCI183491
- 5R37CA259156-04 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.